82W.F HIMS+HERS HERS A DL-0001
- Market cap
- EUR 4.19B
- P/E
- -
- P/B
- 12.63x
- ROE
- -79.3%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is 82W.F undervalued?
Graham numberThe Graham number of HIMS+HERS HERS A DL-0001 cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
HIMS+HERS HERS A DL-0001 fundamental analysis
No fundamental analysis for HIMS+HERS HERS A DL-0001 yet.
HIMS+HERS HERS A DL-0001 stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About HIMS+HERS HERS A DL-0001
Hims & Hers Health, Inc. operates as a consumer-first health and wellness platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, Germany, the Republic of Ireland, France, Spain, Australia, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It als…
Full company profileHIMS+HERS HERS A DL-0001 financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
HIMS+HERS HERS A DL-0001 annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | 527M | 872M | 1.48B | 2.35B | 3.00B |
| Gross Profit | 409M | 715M | 1.17B | 1.73B | 1.85B |
| Operating Income | -68.7M | -29.5M | 61.9M | 106M | -322M |
| EBITDA | -61.2M | -19.9M | 79.0M | 160M | -203M |
| Net Income | -65.7M | -23.5M | 126M | 128M | -282M |
| EPS | -0.32 | -0.11 | 0.57 | 0.56 | -1.20 |
| Balance Sheet | |||||
| Total Assets | 366M | 441M | 708M | 2.15B | 3.55B |
| Total Liabilities | 54.6M | 97.2M | 231M | 1.61B | 3.19B |
| Shareholders' Equity | 312M | 344M | 477M | 541M | 355M |
| Cash & Short-term Investments | 46.8M | 96.7M | 221M | 229M | 606M |
| Cash Flow | |||||
| Operating Cash Flow | -26.5M | 73.5M | 251M | 300M | 158M |
| Capital Expenditure | 7.25M | 26.5M | 52.8M | 243M | 144M |
| Free Cash Flow | -33.8M | 47.0M | 198M | 57.4M | 14.4M |
| Ratios | |||||
| ROE | -21.1% | -6.8% | 26.4% | 23.7% | -79.3% |
| ROA | -17.9% | -5.3% | 17.8% | 6.0% | -7.9% |
| Net Profit Margin | -12.5% | -2.7% | 8.5% | 5.5% | -9.4% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
HIMS+HERS HERS A DL-0001 dividends
HIMS+HERS HERS A DL-0001 has not paid dividends in the last 4 fiscal years.
Who owns HIMS+HERS HERS A DL-0001
- Insiders 4.92%
- Institutions 71.76%
- Public & others 23.32%
- Shares outstanding 226M
- Free float 215M
HIMS+HERS HERS A DL-0001 company profile
- Company name
- HIMS+HERS HERS A DL-0001
- Ticker
- 82W.F
- Exchange
- Frankfurt Exchange
- Sector
- Healthcare
- Industry
- Personal Care Products
- Employees
- 2,442
- Fiscal year end
- December
- Address
- 2269 Chestnut Street, San Francisco, CA, United States, 94123
- Phone
- 415 851 0195
- Website
- hims.com
About HIMS+HERS HERS A DL-0001
Hims & Hers Health, Inc. operates as a consumer-first health and wellness platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, Germany, the Republic of Ireland, France, Spain, Australia, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides personalized health and wellness products; over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, skincare, sexual health and wellness, and hair care under the Hims & Hers brand name; and laboratory testing services to measure a set of biomarkers. Additionally, it offers medical consultation, post-consultation support services, and delivery of laboratory testing results services. Further, the company provides treatments and products for various chronic conditions related to hormone health, weight loss, dermatology, and mental health. The company offers its products through retail partnerships, in stores, and online. The company was formerly known as Hims, Inc. and changed its name to Hims & Hers Health, Inc. in January 2021. The company was founded in 2017 and is based in San Francisco, California.
HIMS+HERS HERS A DL-0001 management
10- Mr. Andrew DudumCo-Founder, Chairman & CEO · born 1988
- Mr. Oluyemi OkupeChief Financial Officer · born 1986
- Mr. Mike ChiChief Operating Officer · born 1980
- Mr. Mohamed ElShenawyChief Technology Officer · born 1975
- Ms. Soleil Teubner Boughton J.D.Chief Legal Officer & Corporate Secretary · born 1978
- Dr. Patrick Carroll M.D.Global Chief Medical Officer · born 1958
- Ms. Deborah M. Autor J.D.Chief Policy Officer & Director · born 1967
- Mr. Jonathan M. FranklinChief Accounting Officer & Principal Accounting Officer · born 1983
- Mr. William James NewbySenior Director of Investor Relations
- Ms. Kathryn H. Beiser B.A., M.S.Chief Communications Officer